LYON, France , April 12, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced the installation of its Ablatherm-HIFU device at the HIFU Clinic in Warsaw, Poland . The HIFU Clinic provides prostate cancer patients in Poland with access to
Provides Funds to Heighten U.S. Lithotripsy Marketing Reduces Debt by 20% LYON, France , March 29, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, outlined today the strengthening of its financial profile and the intended use of proceeds from its
LYON, France , March 23, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of $5.625 million of ordinary shares in the form of
Highlights Reported revenue of EUR 7.5 million ( USD 10.1 million ), up 23% sequentially Sold sixteen lithotripsy devices and one Ablatherm-HIFU device Recorded year-end cash position of EUR 6.5 million following positive cash flow of EUR 1.0 million Streamlined capital structure by issuing 9% USD
LYON, France , March 15, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced today that it will partner with PanAm HIFU to offer minimally invasive HIFU treatment to North American prostate cancer patients, with the installation of an Ablatherm
LYON, France , Feb. 27, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter 2011 results announcement, which will take place on Wednesday, March 21, 2012 , before the opening of the market.
